---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-062041"
form_type: "8-K"
ticker: "ORGO"
cik: "0001661181"
company_name: "Organogenesis Holdings Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:54:30.981012+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Organogenesis Q3 revenue down 7% to $108.5M; net income rises to $3.2M; guides FY rev down 1-4%

## Summary
- Net revenue $108.5M, down $8.3M YoY; Advanced Wound Care fell 7% to $101.4M; Surgical & Sports Med fell 2% to $7.2M.
- Net income $3.2M ($0.02/sh) vs $0.2M ($0.00/sh) in Q3 2022; adjusted net income $5.3M vs $5.1M.
- Adjusted EBITDA $16.0M, up 38% from $11.6M; operating income $8.1M vs $1.8M.
- FY2023 guidance: net revenue $433-446M (down 1-4% YoY); net income $4-9M; adjusted net income $11-17M.
- Revenue impacted by LCD withdrawal issues; profitability improved despite headwinds.

## SEC filing metadata
- accession: 0000950170-23-062041
- form_type: 8-K
- ticker: ORGO
- cik: 0001661181
- company_name: Organogenesis Holdings Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661181/000095017023062041/0000950170-23-062041-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661181/000095017023062041/orgo-20231109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-062041
- JSON: https://secwatch.observer/filing/0000950170-23-062041.json
- Plain text: https://secwatch.observer/filing/0000950170-23-062041.txt

## Key facts
- Earnings Releases
  Organogenesis Holdings Inc. reported the third quarter ended September 30, 2023 results: revenue $108.5 million, net income $3.2 million, EPS $0.02 per share. Guidance reaffirmed.
  - Period: the third quarter ended September 30, 2023
  - Revenue: $108.5 million
  - Net income: $3.2 million
  - EPS: $0.02 per share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Net revenue of $108.5 million for the third quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661181/000095017023062041/0000950170-23-062041-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.